<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=Generator content="Microsoft Word 15 (filtered)">
<title>A3669</title>
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:"Albertus Extra Bold";
	panose-1:2 14 8 2 4 3 4 2 2 4;}
@font-face
	{font-family:Marlett;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:"Segoe UI";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:9.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	background:navy;
	font-size:12.0pt;
	font-family:"Tahoma",sans-serif;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-link:"Balloon Text Char";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:9.0pt;
	font-family:"Segoe UI",sans-serif;
	letter-spacing:.2pt;}
span.11ptChar
	{mso-style-name:11ptChar;
	font-family:"Times New Roman",serif;}
span.BillHead
	{mso-style-name:BillHead;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
span.BillHeading2
	{mso-style-name:BillHeading2;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
span.BillHeadUnBold
	{mso-style-name:BillHeadUnBold;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;}
span.BillLanguage
	{mso-style-name:BillLanguage;
	font-family:"Times New Roman",serif;
	font-style:italic;}
p.bpuBill, li.bpuBill, div.bpuBill
	{mso-style-name:bpuBill;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:26.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuHeadSpon, li.bpuHeadSpon, div.bpuHeadSpon
	{mso-style-name:bpuHeadSpon;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
span.bpuHeadSponChar
	{mso-style-name:bpuHeadSponChar;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuIntro, li.bpuIntro, div.bpuIntro
	{mso-style-name:bpuIntro;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.bpuLegislature, li.bpuLegislature, div.bpuLegislature
	{mso-style-name:bpuLegislature;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:24.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuNormText, li.bpuNormText, div.bpuNormText
	{mso-style-name:bpuNormText;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.bpuReprint, li.bpuReprint, div.bpuReprint
	{mso-style-name:bpuReprint;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:22.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.bpuSponsor, li.bpuSponsor, div.bpuSponsor
	{mso-style-name:bpuSponsor;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuState, li.bpuState, div.bpuState
	{mso-style-name:bpuState;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:32.0pt;
	font-family:"Arial",sans-serif;
	font-weight:bold;}
span.charMarlett
	{mso-style-name:charMarlett;
	font-family:Marlett;}
p.ElevenPt, li.ElevenPt, div.ElevenPt
	{mso-style-name:ElevenPt;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPage, li.FronterPage, div.FronterPage
	{mso-style-name:FronterPage;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPage12pt, li.FronterPage12pt, div.FronterPage12pt
	{mso-style-name:FronterPage12pt;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPageBillHeading, li.FronterPageBillHeading, div.FronterPageBillHeading
	{mso-style-name:FronterPageBillHeading;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;}
p.FronterPageTBox2, li.FronterPageTBox2, div.FronterPageTBox2
	{mso-style-name:FronterPageTBox2;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPageTextBox, li.FronterPageTextBox, div.FronterPageTextBox
	{mso-style-name:FronterPageTextBox;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.FronterSameAs, li.FronterSameAs, div.FronterSameAs
	{mso-style-name:FronterSameAs;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.HangingAnAct, li.HangingAnAct, div.HangingAnAct
	{mso-style-name:HangingAnAct;
	mso-style-link:"HangingAnAct Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.HangingAnActChar
	{mso-style-name:"HangingAnAct Char";
	mso-style-link:HangingAnAct;
	letter-spacing:.2pt;}
span.Para10pt
	{mso-style-name:Para10pt;
	font-family:"Times New Roman",serif;}
p.Pg2Footer, li.Pg2Footer, div.Pg2Footer
	{mso-style-name:Pg2Footer;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:8.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.StyleFronterPage11pt, li.StyleFronterPage11pt, div.StyleFronterPage11pt
	{mso-style-name:"Style FronterPage + 11 pt";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.StyleFronterPageLoweredby3pt, li.StyleFronterPageLoweredby3pt, div.StyleFronterPageLoweredby3pt
	{mso-style-name:"Style FronterPage + Lowered by  3 pt";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	position:relative;
	top:3.0pt;}
p.StyleFronterSameAsPatternSolid100White, li.StyleFronterSameAsPatternSolid100White, div.StyleFronterSameAsPatternSolid100White
	{mso-style-name:"Style FronterSameAs + Pattern\: Solid \(100%\) \(White\)";
	margin:0in;
	margin-bottom:.0001pt;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.Style1, li.Style1, div.Style1
	{mso-style-name:Style1;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
span.Whereas
	{mso-style-name:Whereas;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
span.Style10pt
	{mso-style-name:"Style 10 pt";
	font-family:"Times New Roman",serif;}
p.FronterPageNOCAPS, li.FronterPageNOCAPS, div.FronterPageNOCAPS
	{mso-style-name:FronterPageNOCAPS;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.bpuWpGraphic, li.bpuWpGraphic, div.bpuWpGraphic
	{mso-style-name:bpuWpGraphic;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.sponUdate, li.sponUdate, div.sponUdate
	{mso-style-name:sponUdate;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
span.fronterpagebillhead
	{mso-style-name:fronterpagebillhead;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;}
p.FPHangingAnAct, li.FPHangingAnAct, div.FPHangingAnAct
	{mso-style-name:FPHangingAnAct;
	mso-style-link:"FPHangingAnAct Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.4in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.FPHangingAnActChar
	{mso-style-name:"FPHangingAnAct Char";
	mso-style-link:FPHangingAnAct;
	letter-spacing:.2pt;}
span.LeftBrackt
	{mso-style-name:LeftBrackt;
	font-family:"Albertus Extra Bold",sans-serif;
	font-weight:bold;}
span.RightBrackt
	{mso-style-name:RightBrackt;
	font-family:"Albertus Extra Bold",sans-serif;
	font-weight:bold;}
span.BoldItal
	{mso-style-name:BoldItal;
	font-weight:bold;
	font-style:italic;}
p.HangingSup, li.HangingSup, div.HangingSup
	{mso-style-name:HangingSup;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.HangingTableBottom, li.HangingTableBottom, div.HangingTableBottom
	{mso-style-name:HangingTableBottom;
	margin-top:0in;
	margin-right:1.0in;
	margin-bottom:0in;
	margin-left:.8in;
	margin-bottom:.0001pt;
	text-indent:-.8in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.HangingTableTop, li.HangingTableTop, div.HangingTableTop
	{mso-style-name:HangingTableTop;
	margin-top:0in;
	margin-right:.5in;
	margin-bottom:0in;
	margin-left:.8in;
	margin-bottom:.0001pt;
	text-indent:-.8in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.BalloonTextChar
	{mso-style-name:"Balloon Text Char";
	mso-style-link:"Balloon Text";
	font-family:"Segoe UI",sans-serif;
	letter-spacing:.2pt;}
.MsoChpDefault
	{font-size:10.0pt;}
 /* Page Definitions */
 @page WordSection1
	{size:8.5in 14.0in;
	margin:1.5in 1.0in 1.0in 1.0in;}
div.WordSection1
	{page:WordSection1;}
@page WordSection2
	{size:8.5in 14.0in;
	margin:1.0in 113.75pt 1.0in 113.75pt;}
div.WordSection2
	{page:WordSection2;}
@page WordSection3
	{size:8.5in 14.0in;
	margin:1.0in 1.75in 1.3in 2.0in;}
div.WordSection3
	{page:WordSection3;}
-->
</style>

</head>

<body lang=EN-US>

<div class=WordSection1>

<p class=bpuBill><a name=bpuFrontPg></a>ASSEMBLY, No. 3669 </p>

<p class=bpuWpGraphic><b><span style='font-size:32.0pt;line-height:120%;
font-family:"Arial",sans-serif;letter-spacing:0pt'>STATE OF NEW JERSEY</span></b></p>

<p class=bpuLegislature>221st LEGISLATURE</p>

<p class=bpuWpGraphic>  </p>

<p class=bpuIntro>INTRODUCED FEBRUARY 12, 2024</p>

<p class=bpuIntro>&nbsp;</p>

</div>

<span style='font-size:11.0pt;line-height:120%;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:auto'>
</span>

<div class=WordSection2>

<p class=bpuIntro>&nbsp;</p>

<p class=bpuSponsor>Sponsored by:</p>

<p class=bpuSponsor>Assemblywoman  CAROL A. MURPHY</p>

<p class=bpuSponsor>District 7 (Burlington)</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>SYNOPSIS</p>

<p class=bpuNormText>     Authorizes use of healthcare platforms providing
discounted prices for payment of prescription and non-prescription drugs or
devices and for telehealth and telemedicine services. </p>

<p class=bpuNormText>&nbsp;</p>

<p class=bpuSponsor>CURRENT VERSION OF TEXT </p>

<p class=bpuNormText>     As introduced.</p>

<p class=bpuNormText>   </p>

</div>

<span style='font-size:12.0pt;line-height:120%;font-family:"Times New Roman",serif;
letter-spacing:.2pt'><br clear=all style='page-break-before:always'>
</span>

<div class=WordSection3>

<p class=HangingAnAct style='line-height:150%'><span class=BillHead>An Act</span><span
class=HangingAnActChar> </span>concerning payment for certain health-related
costs, amending and supplementing various parts of the statutory law.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     <span class=BillHeading2>Be It
Enacted </span><span class=BillLanguage>by the Senate and General Assembly of
the State of New Jersey:</span></p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      1.   Section
1 of P.L.2019, c.257 (C.17B:27F-6) is amended to read as follows:</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      1.   a.
A pharmacy benefits manager, in connection with any contract or arrangement
with a private health insurer, prescription benefit plan, or the State Health
Benefits Program or School Employees' Health Benefits Program, shall not
require a covered person to make a payment at the point of sale for any amount
for a deductible, coinsurance payment, or a copayment for a prescription drug
benefit in an amount that exceeds the amount permitted pursuant to subsection
d. of section 3 of P.L.2023, c.107 (C.17B:27F-3.1).</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      b.   A
pharmacy benefits manager shall not prohibit a network pharmacy from, and shall
not apply a penalty or any other type of disincentive to a network pharmacy
for:</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (1)
disclosing to a covered person lower cost prescription drug options, including
those that are available to the covered person if the covered person purchases
the prescription drug without using health insurance coverage;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (2)
providing a covered person with the option of paying the pharmacy provider's
cash price for the purchase of a prescription drug and not filing a claim with
the covered person's health benefits plan if the cash price is less than the
covered person's cost-sharing amount; </span><b><span style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b><span
style='letter-spacing:0pt'>or</span><b><span style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (3)
providing information to a State or federal agency, law enforcement agency, or
the department when such information is required by law<u>; or</u></span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      <u>(4)  applying
a discounted price generated by a healthcare platform, as defined pursuant to
section 2 of P.L.2003, c.280 (C.45:14-41), to the payment of a covered person
with an account or membership to the healthcare platform for a prescription
drug, even if the covered person maintains health insurance coverage</u>.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      c.   Any
provision of a contract that conflicts with the provisions of subsection b. of
this section shall be void and unenforceable.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      d.   A
violation of this section shall be an unlawful practice and a violation of
P.L.1960, c.39 (C.56:8-1 et seq.), and shall also be subject to any enforcement
action that the Commissioner of Banking and Insurance is authorized to take
pursuant to section 5 of P.L.2015, c.179 (C.17B:27F-5).</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>(cf:
P.L.2023, c.107, s.10)</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:150%'>     2.    Section 2 of P.L.2003,
c.280 (C.45:14-41) is amended to read as follows:</p>

<p class=MsoNormal style='line-height:150%'>     2.    As used in this act:</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Administer&quot; means
the direct application of a drug to the body of a patient or research subject
by subcutaneous, intramuscular or intradermal injection, inhalation or
ingestion by a pharmacist engaged in collaborative practice or in accordance
with regulations jointly promulgated by the board and the State Board of
Medical Examiners.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Automated medication
device&quot; means a discrete unit that performs specific drug dispensing
operations.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Automated medication
system&quot; means any process that performs operations or activities, other
than compounding or administration, relative to the storage, packaging,
dispensing and distribution of medications and which collects, controls and
maintains all transaction information.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Board of Pharmacy&quot;
or &quot;board&quot; means the New Jersey State Board of Pharmacy.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Certification&quot;
means a certification awarded by a recognized non-government specialty
organization to signify that a pharmacist has met predetermined qualifications
and to signify to the public that the pharmacist is competent to practice in
the designated specialty.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Collaborative drug
therapy management&quot; means a written protocol directed on a voluntary basis
by a patient's physician, with the patient's consent, that is between a
patient's physician who is treating the patient for a specific disease and a
pharmacist for cooperative management of a patient's drug, biological and
device-related health care needs, which shall be conducted in accordance with
regulations jointly promulgated by the board and the State Board of Medical
Examiners and shall only include the collecting, analyzing and monitoring of
patient data; ordering or performing of laboratory tests based on the standing
orders of a physician as set forth in the written protocol; ordering of
clinical tests based on the standing orders of a physician as set forth in the
written protocol, provided those laboratory tests are granted waived status in
accordance with the provisions of the &quot;New Jersey Clinical Laboratory
Improvement Act,&quot; P.L.1975, c.166 (C.45:9-42.26 et seq.) and are for the
treatment of a disease state identified jointly by the board and the State
Board of Medical Examiners as subject to collaborative drug therapy management;
modifying, continuing or discontinuing drug or device therapy; and therapeutic
drug monitoring with appropriate modification to dose, dosage regimen, dosage
forms or route of administration.  The interpretation of clinical or laboratory
tests under a written protocol may only be performed by a pharmacist in direct
consultation with a physician.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Compounding&quot; means
the preparation, mixing, assembling, packaging or labeling of a drug or device
as the result of a practitioner's prescription or initiative based on the
relationship of the practitioner or patient with the pharmacist in the course
of professional practice or for the purpose of, or incident to, research,
teaching or chemical analysis and not for sale or dispensing.  Compounding also
includes the preparation of drugs or devices in anticipation of prescription
drug orders based on routine, regularly observed prescribing patterns.  Nothing
in this act is meant to limit a prescriber's ability under pre-existing law to
order a compounded medication for use in the prescriber's practice, as
permitted by State and federal law.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Confidential
information&quot; means information that is identifiable as to the patient
involved that a pharmacist accesses, transmits or maintains in a patient's
record or which is communicated to or by the patient as part of patient
counseling.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Credentialing&quot;
means the process by which an approved academic institution awards a
certificate to signify that the credentialed pharmacist has completed the
required courses, examinations or both, that indicate advanced knowledge of a
particular area of pharmacy.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Deliver&quot; or
&quot;delivery&quot; means the actual, constructive or attempted transfer of a
drug or device from one person to another, whether or not for consideration.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Device&quot; means an
instrument, apparatus, implement, machine, contrivance, implant or other similar
or related article, including any component part or accessory, which is
required under federal law to bear the label &quot;RX Only.&quot;</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Dispense&quot; or
&quot;dispensing&quot; means the procedure entailing the interpretation of a
practitioner's prescription order for a drug, biological or device, and
pursuant to that order the proper selection, measuring, compounding, labeling
and packaging in a proper container for subsequent administration to, or use
by, a patient.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Dosage form&quot; means
the physical formulation or medium in which the product is intended,
manufactured and made available for use, including, but not limited to:
tablets, capsules, oral solutions, aerosols, inhalers, gels, lotions, creams,
ointments, transdermals and suppositories, and the particular form of the above
which utilizes a specific technology or mechanism to control, enhance or direct
the release, targeting, systemic absorption or other delivery of a dosage
regimen in the body.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Drug or medication&quot;
means articles recognized as drugs in any official compendium, or supplement
thereto, designated from time to time by the board for use in the diagnosis,
cure, mitigation, treatment or prevention of disease in humans or other
animals; articles intended for use in the diagnosis, cure, mitigation, treatment
or prevention of disease in humans or other animals; articles intended to
affect the structure or any function of the body of humans or other animals,
except that a food, dietary ingredient or dietary supplement, as those terms
are defined in 21 U.S.C.s.321, is not a drug solely because the label or the
labeling contains such a claim; and articles intended for use as a component of
and articles specified in this definition of &quot;drug or medication.&quot;</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Drug utilization
review&quot; includes, but is not limited to, the following activities:</p>

<p class=MsoNormal style='line-height:150%'>     (1)   Evaluation of
prescription drug orders and patient records for known allergies, rational
therapy-contraindications, appropriate dose and route of administration and
appropriate directions for use;</p>

<p class=MsoNormal style='line-height:150%'>     (2)   Evaluation of prescription
drug orders and patient records for duplication of therapy;</p>

<p class=MsoNormal style='line-height:150%'>     (3)   Evaluation of
prescription drug orders and patient records for interactions between
drug-drug, drug-food, drug-disease and adverse drug reactions; and</p>

<p class=MsoNormal style='line-height:150%'>     (4)   Evaluation of
prescription drug orders and patient records for proper utilization, including
over- or under-utilization, and optimum therapeutic outcomes.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Extern&quot; means any
person who is in the fifth or sixth year of college or the third or fourth
professional year, at an accredited school or college of pharmacy approved by
the board, who is assigned to a training site for the purpose of acquiring
accredited practical experience under the supervision of the school or college
at which the person is enrolled.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Electronic means&quot;
means any electronic or digital transmission format, including facsimile or
computer generated messaging.</p>

<p class=MsoNormal style='line-height:150%'>     <u>Healthcare platform means
an Internet-based service through which a consumer, who may or may not have
separate health insurance coverage, may set-up an account or become a member to
obtain discounts on prescription or non-prescription drugs or devices and
through which other services, including telemedicine, may be provided.</u></p>

<p class=MsoNormal style='line-height:150%'>     &quot;Immediate
supervision&quot; means a level of control which assures that the pharmacist is
physically present at the pharmacy practice site and has the responsibility for
accuracy and safety with respect to the actions of pharmacy technicians,
interns and externs.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Intern&quot; means any
person who has graduated from an accredited school or college of pharmacy
approved by the board, or if a foreign pharmacy graduate, any person who has
met all of the requirements of the board, and who is being trained by an
approved preceptor for the purpose of acquiring accredited practical experience
and who has first registered for that purpose with the board.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Labeling&quot; means the
process of preparing and affixing a label to any drug container, exclusive
however, of the labeling by a manufacturer, packer or distributor of a
non-prescription drug or commercially packaged legend drug or device.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Licensure&quot; means
the process by which the board grants permission to an individual to engage in
the practice of pharmacy upon finding that the applicant has attained the
degree of competency necessary to ensure that the public health, safety and
welfare will be protected.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Medication error&quot;
means a preventable event that may cause or lead to inappropriate use of a
medication or patient harm while the medication is in the control of the
practitioner, patient or consumer.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Medication order&quot;
means a prescription for a specific patient in an institutional setting.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Modifying&quot; means to
change a specific drug, the dosage, or route of delivery of a drug currently
being administered for an existing diagnosis pursuant to a collaborative drug
therapy management.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Non-prescription drug or
device&quot; means a drug or device which may be obtained without a
prescription and which is labeled for consumer use in accordance with the
requirements of the laws and rules of this State and the federal government.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Permit&quot; means the
authorization granted by the board to a site to engage in the practice of
pharmacy.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Person&quot; means an
individual, corporation, partnership, association or any other legal entity
including government.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Pharmaceutical
care&quot; means the provision by a pharmacist of drug therapy review and other
related patient care services intended to achieve positive outcomes related to
the treatment, cure or prevention of a disease; control, elimination or
reduction of a patient's symptoms; or arresting or slowing of a disease process
as defined by the rules and regulations of the board.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Pharmacist&quot; means
an individual currently licensed by this State to engage in the practice of
pharmacy.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Pharmacist-in-charge&quot;
means a pharmacist who accepts responsibility for the operation of a pharmacy
practice site in conformance with all laws and rules pertinent to the practice
of pharmacy and the distribution of drugs.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Pharmacist in
collaborative practice&quot; means a pharmacist engaged in the collaborative
drug therapy management of a patient's drug, biological and device-related
health care needs pursuant to a written protocol, in collaboration with a
licensed physician and in accordance with the regulations jointly promulgated
by the board and the State Board of Medical Examiners.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Pharmacy practice
site&quot; means any place in this State where drugs are dispensed or
pharmaceutical care is provided by a licensed pharmacist, but shall not include
a medical office under the control of a licensed physician.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Pharmacy
technician&quot; means an individual working in a pharmacy practice site who,
under the immediate supervision of a pharmacist, assists in pharmacy activities
as permitted by section 41 of this act and the rules and regulations of the
board that do not require the professional judgment of a pharmacist.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Practice of
pharmacy&quot; means a health care service by a pharmacist that includes:
compounding, dispensing and labeling of drugs, biologicals, radio
pharmaceuticals or devices; overseeing automated medication systems;
interpreting and evaluating prescriptions; administering and distributing
drugs, biologicals and devices; maintaining prescription drug records; advising
and consulting on the therapeutic values, content, hazards and uses of drugs,
biologicals and devices; managing and monitoring drug therapy; collecting,
analyzing and monitoring patient data; performing drug utilization reviews;
storing prescription drugs and devices; supervising technicians, interns and
externs; and such other acts, services, operations or transactions necessary,
or incidental to, providing pharmaceutical care and education.  In accordance
with written guidelines or protocols established with a licensed physician, the
&quot;practice of pharmacy&quot; also includes collaborative drug therapy
management including modifying, continuing or discontinuing drug or device
therapy; ordering or performing of laboratory tests under collaborative drug
therapy management; and ordering clinical tests, excluding laboratory tests,
unless those tests are part of collaborative drug therapy management.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Practitioner&quot; means
an individual currently licensed, registered or otherwise authorized by the
jurisdiction in which the individual practices to administer or prescribe drugs
in the course of professional practice.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Preceptor&quot; means an
individual who is a pharmacist, meets the qualifications under the rules and
regulations of the board, and participates in the instructional training of
pharmacy interns and externs.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Prescription&quot; means
a lawful order of a practitioner for a drug, a device or diagnostic agent for a
specific patient.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Prescription drug&quot;
or &quot;legend drug&quot; means a drug which, under federal law, is required
to be labeled prior to being delivered to the pharmacist, with either of the
following statements: &quot;Rx Only&quot; or &quot;Caution: Federal law
restricts this drug to use by, or on the order of, a licensed
veterinarian&quot; or is required by any applicable federal or state law, rule
or regulation to be dispensed pursuant to a prescription drug order or is
restricted to use by a practitioner only.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Registration&quot; means
the process of making a list or being enrolled in an existing list.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Therapeutic
interchange&quot; means the substitution and dispensing of a drug chemically
dissimilar from the prescription drug originally prescribed.</p>

<p class=MsoNormal style='line-height:150%'>(cf: P.L.2003, c.280, s.2)</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     3.    Section 26 of P.L.2003,
c.280 (C.45:14-65) is amended to read as follows:</p>

<p class=MsoNormal style='line-height:150%'>     26.  In addition to the
provisions of section 8 of P.L.1978, c.73 (C.45:1-21), the board may refuse an
application for examination or may suspend or revoke the certificate of a
licensed pharmacist upon proof satisfactory to the board that such licensed
pharmacist is guilty of grossly unprofessional conduct and the following acts
are hereby declared to constitute grossly unprofessional conduct for the
purpose of this act:</p>

<p class=MsoNormal style='line-height:150%'>     a.     Paying rebates or
entering into an agreement for payment of rebates to any physician, dentist or
other person for the recommending of the services of any person.</p>

<p class=MsoNormal style='line-height:150%'>     b.    The providing or causing
to be provided to a physician, dentist, veterinarian or other person authorized
to prescribe, prescription blanks or forms bearing the pharmacist's or
pharmacy's name, address or other means of identification.</p>

<p class=MsoNormal style='line-height:150%'>     c.     The claiming of
professional superiority in the compounding or filling of prescriptions or in
any manner implying professional superiority which may reduce public confidence
in the ability, character or integrity of other pharmacists.</p>

<p class=MsoNormal style='line-height:150%'>     d.    Fostering the interest
of one group of patients at the expense of another which compromises the
quality or extent of professional services or facilities made available.</p>

<p class=MsoNormal style='line-height:150%'>     e.     The distribution of
premiums or rebates of any kind whatsoever in connection with the sale of drugs
and medications provided, however, that trading stamps and similar devices
shall not be considered to be rebates for the purposes of this act and provided
further that discounts, premiums and rebates may be provided in connection with
the sale of drugs and medications to any person who is 60 years of age or older
<u>and that discounts may be provided to any person who is a member of or is an
account holder with a healthcare platform</u>.</p>

<p class=MsoNormal style='line-height:150%'>     f.     Advertising of
prescription drug prices in a manner inconsistent with rules and regulations
promulgated by the Director of the Division of Consumer Affairs, except that no
advertising of any drug or substance shall be authorized unless the
Commissioner of Health and Senior Services shall have determined that the
advertising is not harmful to public health, safety and welfare. </p>

<p class=MsoNormal style='line-height:150%'>     g.    Engaging in activities
beyond the scope of a collaborative drug therapy management agreement.</p>

<p class=MsoNormal style='line-height:150%'>     Before a certificate shall be
refused, suspended or revoked, the accused person shall be furnished with a
copy of the complaint and given a hearing before the board.  Any person whose
certificate is so suspended or revoked shall be deemed an unlicensed person
during the period of such suspension or revocation, and as those shall be
subject to the penalties prescribed in this act, but that person may, at the
discretion of the board, have his certificate reinstated at any time without an
examination, upon application to the board.  Any person to whom a certificate
shall be denied by the board or whose certificate shall be suspended or revoked
by the board shall have the right to review that action by appeal to the
Appellate Division of the Superior Court in lieu of prerogative writ.</p>

<p class=MsoNormal style='line-height:150%'>(cf: P.L.2003, c.280, s.26)<br
clear=all style='page-break-before:always'>
</p>

<p class=MsoNormal style='line-height:150%'>     4.    (New section) A patient
with a membership or account with a healthcare platform may apply the membership
or account as part of the payment for a prescription or non-prescription drug
or device.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     5.    (New section) A patient
with a membership or an account with a healthcare platform, as defined pursuant
to section 2 of P.L.2003, c.280 (C.45:14-41), may apply the membership or
account towards payment of services provided as a result of telehealth or
telemedicine.  A patient who uses or intends to use a membership or an account
with a healthcare platform to pay for telehealth or telemedicine services shall
notify a provider of any identification number, if given, in connection with
the membership or account with a healthcare platform to ensure the preservation
of a proper patient-provider relationship pursuant to section 3 of P.L.2017,
c.117 (C.45:1-63).</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     6.    This act shall take
effect immediately.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal align=center style='text-align:center;line-height:150%'>STATEMENT</p>

<p class=MsoNormal align=center style='text-align:center;line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'><span style='line-height:150%;
letter-spacing:0pt'>      This bill incorporates the use of healthcare
platforms such as GoodRx and SingleCare into the laws governing pharmacy
benefits managers, pharmacists and telehealth.  Healthcare platform is defined
in the bill as an Internet-based service through which a consumer, who may or
may not have separate health insurance coverage, may set-up an account or
become a member to obtain discounts on prescription or non-prescription drugs
or devices and through which other services, including telemedicine, may be
provided.  The bill authorizes patients to use a membership or an account with
a healthcare platform and to stipulate that a licensee of the Board of Pharmacy
will not be penalized for allowing a patient to use a discount from a
healthcare platform as part of payment.  The bill also stipulates that a
pharmacy benefits manager is to not prohibit or apply any penalty or
disincentive to a network pharmacy if a discounted price generated by a
healthcare platform is applied to the payment made by a covered person with an
account or membership to the healthcare platform for a prescription drug even
if the covered person maintains health insurance coverage.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='line-height:150%;
letter-spacing:0pt'>      Additionally, the bill allows a patient with a
membership or an account in a healthcare platform to apply the membership or
account towards payment of services provided as a result of telehealth or
telemedicine.  The patient is to notify a provider of any identification
number, if given, in connection with the membership or account with a
healthcare platform to ensure the preservation of a proper patient-provider
relationship.</span></p>

</div>

</body>

</html>
